duplication

Digital

At the heart of every pharma company lies a big problem: medical affairs and commercial teams are independently creating the same content.

News

Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.